142 related articles for article (PubMed ID: 6897931)
1. Synthesis and metabolic clearance of 1,25-dihydroxyvitamin D as determinants of serum concentrations: a comparison of two methods.
Maierhofer WJ; Gray RW; Adams ND; Smith GA; Lemann J
J Clin Endocrinol Metab; 1981 Sep; 53(3):472-5. PubMed ID: 6897931
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D metabolism in hypoparathyroidism.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875
[TBL] [Abstract][Full Text] [Related]
3. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
Gray RW; Wilz DR; Caldas AE; Lemann J
J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
[TBL] [Abstract][Full Text] [Related]
4. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
6. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
8. Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.
Yamato H; Matsumoto T; Fukumoto S; Ikeda K; Ishizuka S; Ogata E
Endocrinology; 1989 Jan; 124(1):511-7. PubMed ID: 2783309
[TBL] [Abstract][Full Text] [Related]
9. Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers.
Gascon-Barré M; D'Amour P; Dufresne L; Perreault JP
Ann Nutr Metab; 1985; 29(5):289-96. PubMed ID: 3876804
[TBL] [Abstract][Full Text] [Related]
10. Hypoparathyroidism during pregnancy: treatment with calcitriol.
Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
[TBL] [Abstract][Full Text] [Related]
11. Conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in renal slices from the rat.
Armbrecht HJ; Zenser TV; Davis BB
Endocrinology; 1981 Jul; 109(1):218-22. PubMed ID: 6972300
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
[TBL] [Abstract][Full Text] [Related]
13. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.
Broadus AE; Horst RL; Lang R; Littledike ET; Rasmussen H
N Engl J Med; 1980 Feb; 302(8):421-6. PubMed ID: 7351950
[TBL] [Abstract][Full Text] [Related]
14. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3.
Marx SJ; Swart EG; Hamstra AJ; DeLuca HF
J Clin Endocrinol Metab; 1980 Nov; 51(5):1138-42. PubMed ID: 6893458
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
16. Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism.
Braun JJ; Juttmann JR; Visser TJ; Birkenhäger JC
Clin Endocrinol (Oxf); 1982 Jul; 17(1):21-8. PubMed ID: 6981468
[TBL] [Abstract][Full Text] [Related]
17. [Plasma vitamin D metabolites in parathyroid diseases (author's transl)].
Unakami H
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):234-47. PubMed ID: 6980145
[TBL] [Abstract][Full Text] [Related]
18. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria.
Insogna KL; Broadus AE; Dreyer BE; Ellison AF; Gertner JM
J Clin Endocrinol Metab; 1985 Sep; 61(3):490-5. PubMed ID: 2991323
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Mar; 50(3):480-4. PubMed ID: 6892641
[TBL] [Abstract][Full Text] [Related]
20. Extrarenal synthesis of 1,25-dihydroxyvitamin D: sensitivity to glucocorticoid treatment.
Adami S; Graziani G; Tartarotti D; Cappelli R; Casati S; Cantaluppi A; Braga V; Lo Cascio V
Clin Sci (Lond); 1987 Mar; 72(3):329-34. PubMed ID: 3493110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
